Replies to post #339375 on Elite Pharmaceuticals Inc (ELTP)

[The ELTP King]

The one product of those five Elite still has, Nasrat is afraid to launch it.

But why didn't he wait until the market stabilizes for the other four products like he's doing for Generic Tylenol with Codeine?

He sold the other four for pennies on the dollar, with two of them in much bigger markets.


Acetaminophen and Codeine Phosphate

The Company received approval from the FDA of an ANDA for a generic version of Tylenol® with Codeine (acetaminophen and codeine phosphate) 300mg/7.5mg, 300mg/15mg, 300mg/30mg and 300mg/60mg tablets. Acetaminophen with codeine is a combination medication indicated for the management of mild to moderate pain, where treatment with an opioid is appropriate and for which alternative treatments are inadequate. Acetaminophen with codeine products have annual U.S. sales of approximately $45 million according to IQVIA (formerly QuintilesIMS Health Data). The Company is not pursuing licensing deals for any opioids at this time until the market changes. The Company will wait for the market to stabilize before pursuing these opportunities.

Percocet... approved 7/18... $500M... 16 competitors
Norco... approved 11/18... $447M... 11 competitors
Tyl w codeine...approved 9/19... $45M... 8 competitors
Methadone... approved 8/18... $30M... 10 competitors
hydromorphone... approved 1/12... $30M... 8 competitors

[Jeff Invest]

Reality sets in. Queue curtain

[NASDAQ2020]

$ 1 billlion Combined market with 50 competitors.
Someone will do the math.